Carly Szabo, Assistant Editor

Obesity leads to biomechanical changes that create the right conditions for tumor growth.

Dispensing medical marijuana may soon become an issue for specialty pharmacy.

Oncologists will now be able to measure progress in cancer treatments.

Addition of docetaxel had the greatest benefit in patients with a high burden of metastatic disease.

Discovery holds promise for patients with Crohn's disease, diabetes, ulcerative colitis, and more.

RA drug found to improve physical and emotional well-being among patients.

Genentech official sheds light on the current cancer drug pipeline.

Findings could lead to effective new cancer treatments.

Findings may lead to safer cancer treatments without side effects harmful to the brain.

Protein may hold key to eradicating cancer cells.

Long-term aspirin use may lessen colorectal cancer risk.

Link found between race and breast cancer life expectancy.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Psoriasis treatment may improve more than just skin issues.

Research may lead to improve rheumatoid arthritis treatment.

Drug shows promise treating chronic and potentially life-threatening skin disease.

Health care professionals advised to discontinue drug regimen when appropriate.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

Beta-blockers found reduce to stress from hormones that fuel disease progression.

Study may help improve early cancer detection.

Findings may better predict organ rejection before transplantation.

Device may eventually detect cancer and diabetes.

Researchers target the spread of diseases such as HIV, SARS, and Ebola.

Cancer drug may benefit patients with specific genetic mutation.

Researchers evaluate how PTEN protein regulates cell growth and how mutations can lead to cancer.

Data tracking may someday become a key component in limiting disease spread.

Researchers shed light on association between alcohol consumption and cancer.

Doppler system correctly identified 100% of patients with malignant skin cancer.

Cancer drug significantly reduces the risk for clinically relevant non-major bleeding.

Findings could lead to more effective treatments for diseases such as cancer and multiple sclerosis.